These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38275509)

  • 1. Impact of Disease Modifying Therapy on MS-Related Fatigue: A Narrative Review.
    Elkhooly M; Bao F; Bernitsas E
    Brain Sci; 2023 Dec; 14(1):. PubMed ID: 38275509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of disease modifying therapies on fatigue in multiple sclerosis.
    Cruz Rivera S; Aiyegbusi OL; Piani Meier D; Dunne A; Harlow DE; Henke C; Kamudoni P; Calvert MJ
    Mult Scler Relat Disord; 2023 Nov; 79():105065. PubMed ID: 37839365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hiding in plain sight: The magnitude of unused disease modifying therapies in multiple sclerosis and strategies for reducing the economic burden of care.
    Okuda DT; Burgess KW; Cook K; McCreary M; Winkler MD; Moog TM
    Mult Scler Relat Disord; 2022 Jul; 63():103920. PubMed ID: 35661567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis.
    Freeman L; Longbrake EE; Coyle PK; Hendin B; Vollmer T
    CNS Drugs; 2022 Dec; 36(12):1285-1299. PubMed ID: 36350491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise therapy for fatigue in multiple sclerosis.
    Heine M; van de Port I; Rietberg MB; van Wegen EE; Kwakkel G
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009956. PubMed ID: 26358158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies.
    Burtchell J; Clemmons D; Clemmons J; Sabutis T; Rosenberg A; Graves J; Sweeney ML; Kramer J; Ziehn M; Brown B; Weiss JL; Obeidat AZ
    Neurol Ther; 2022 Sep; 11(3):955-979. PubMed ID: 35608740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden.
    Teni FS; Machado A; Murley C; He A; Fink K; Gyllensten H; Glaser A; Alexanderson K; Hillert J; Friberg E
    Mult Scler Relat Disord; 2023 Jan; 69():104456. PubMed ID: 36529068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential pathophysiological pathways that can explain the positive effects of exercise on fatigue in multiple sclerosis: A scoping review.
    Langeskov-Christensen M; Bisson EJ; Finlayson ML; Dalgas U
    J Neurol Sci; 2017 Feb; 373():307-320. PubMed ID: 28131211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-modifying therapy prescription patterns in people with multiple sclerosis by age.
    Zhang Y; Salter A; Jin S; Culpepper WJ; Cutter GR; Wallin M; Stuve O
    Ther Adv Neurol Disord; 2021; 14():17562864211006499. PubMed ID: 33868459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "No association between disease modifying treatment and fatigue in multiple sclerosis".
    Broch L; Flemmen HØ; Simonsen CS; Berg-Hansen P; Ormstad H; Brunborg C; Celius EG
    Mult Scler Relat Disord; 2023 Nov; 79():104993. PubMed ID: 37708819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
    Menzin J; Caon C; Nichols C; White LA; Friedman M; Pill MW
    J Manag Care Pharm; 2013; 19(1 Suppl A):S24-40. PubMed ID: 23383731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting.
    Lanzillo R; Sparaco M; Lavorgna L; Carmisciano L; Signoriello E; Signori A; Costabile T; Maniscalco GT; Saccà F; Cepparulo S; Russo CV; Bisecco A; Frattaruolo N; Strianese A; Lus G; Brescia Morra V; Bonavita S
    Neurol Sci; 2020 Nov; 41(11):3235-3241. PubMed ID: 32388646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
    Polick CS; Ploutz-Snyder R; Braley TJ; Connell CM; Stoddard SA
    PLoS One; 2023; 18(10):e0292233. PubMed ID: 37851620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a link between inflammation and fatigue in multiple sclerosis?
    Chalah MA; Ayache SS
    J Inflamm Res; 2018; 11():253-264. PubMed ID: 29922081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teriflunomide for multiple sclerosis.
    He D; Zhang C; Zhao X; Zhang Y; Dai Q; Li Y; Chu L
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009882. PubMed ID: 27003123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yoga as an intervention to manage multiple sclerosis symptoms.
    Thakur P; Mohammad A; Rastogi YR; Saini RV; Saini AK
    J Ayurveda Integr Med; 2020; 11(2):114-117. PubMed ID: 31248778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.
    Meltzer E; Charron O; Wozny J; Onuorah H; Montague A; Kline AC; Largent A; Krause TM; Freeman L
    Mult Scler Relat Disord; 2023 Dec; 80():105085. PubMed ID: 37931487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review.
    Oliva Ramirez A; Keenan A; Kalau O; Worthington E; Cohen L; Singh S
    BMC Neurol; 2021 Dec; 21(1):468. PubMed ID: 34856949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Treatment of Multiple Sclerosis: A Review.
    McGinley MP; Goldschmidt CH; Rae-Grant AD
    JAMA; 2021 Feb; 325(8):765-779. PubMed ID: 33620411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.